Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India.

by Suman Kanungo, Anna Lena Lopez, Mohammad Ali, Byomkesh Manna, Deok Ryon Kim, Tanmay Mahapatra, Jan Holmgren, Mandeep S Dhingra, Thomas F Weirzba, G Balakrish Nair, Sujit K Bhattacharya, John D Clemens, Dipika Sur
Published 2014-01-01

Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India.

by Venkata Raghava Mohan, Santosh Raj, Mandeep Singh Dhingra, Naveena Aloysia D'Cor, Ajit Pal Singh, Tarun Saluja, Deok Ryun Kim, Venkat Jayanth Midde, Yanghee Kim, Sridhar Vemula, Santhosh Kumar Narla, Binod Sah, Mohammad Ali
Published 2019-01-01

Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone.

by Suman Kanungo, Sachin N Desai, Ranjan Kumar Nandy, Mihir Kumar Bhattacharya, Deok Ryun Kim, Anuradha Sinha, Tanmay Mahapatra, Jae Seung Yang, Anna Lena Lopez, Byomkesh Manna, Barnali Bannerjee, Mohammad Ali, Mandeep Singh Dhingra, Ananga Mohan Chandra, John D Clemens, Dipika Sur, Thomas F Wierzba
Published 2015-03-01